Loading stock data…
Teleflex Incorporated (TFX)
$137.23-1.13 (-0.82%)
Market OpenUpdated 3:47 PM EDT
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Teleflex Incorporated in the Healthcare sector is trading at $137.23 with a market capitalization of $5.7B. Wall Street consensus targets $153.55 (11 analysts), implying a +11.9% move over the next 12 months. The stock is currently near its 52-week high of $145.00, remaining 11.8% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +11.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $570.33M↑ | $548.26M↑ | -$401.87M↓ | $913.02M↑ | $442.52M |
| Gross Profit | $331.71M↑ | $307.43M↑ | -$151.41M↓ | $451.64M↑ | $265.83M |
| Operating Income | $73.07M↑ | $37.03M↑ | -$164.65M↓ | $112.65M↑ | $101.84M |
| Net Income | $99.69M↑ | -$8.15M↑ | -$714.33M↓ | -$408.89M↓ | $122.58M |
Peer Comparison
JNJUNHPFE
Fundamentals
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.69B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
2142.67
Beta
Defensive asset. Lower volatility than the S&P 500.
0.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.74%
ROE
Average efficiency. Growth may require heavy reinvestment.
-32.71%
Volume
Today's trading volume
352,472
Recent News
Should You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push
On August 6, Teleflex Incorporated (NYSE:TFX) reported second-quarter results for the period ended June 30, and the numbers told two different stories at once. Revenue from continuing operations climbed to $570.3 million, up 28.9% from a year earlier, while GAAP diluted earnings per share slid to $0.96 from $1.54. Add in a completed divestiture, a […]
Medtronic Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
MDT beats Q1 earnings and revenue estimates as broad-based growth drives shares higher and prompts a fiscal 2027 guidance boost.
Is This the Right Time to Add CRL Stock to Your Portfolio?
Charles River's improving DSA demand and strategic investments support growth, but uneven recovery and NHP cost volatility remain key risks.
Teleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales
Teleflex stock has delivered a sharp decline for long term holders over the past five years, yet today the intrinsic value estimate points to a discount while market based multiples suggest the shares are not cheap. That split, combined with the stock’s recent rebound, puts the current Teleflex valuation under closer scrutiny for investors trying to decide what the market is really pricing in. Teleflex has fallen about 63.6% over five years, which means recent gains still sit against a deep...